Your session is about to expire
← Back to Search
EVAHEART®2 LVAS for Heart Failure (COMPETENCE Trial)
COMPETENCE Trial Summary
This trial will compare the EVA2 LVAS to the most recent magnetically levitated centrifugal LVAS (HM3 LVAS) to see if it is non-inferior.
COMPETENCE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCOMPETENCE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.COMPETENCE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am using an Impella device and have symptoms like blood in urine and high LDH levels.Your blood platelet count is less than 100,000 per milliliter.I have health issues that make surgery very risky for me.You are currently using a mechanical circulatory support device, except for IABP, Impella 5.0, or 5.5.I have an untreated large abdominal aortic aneurysm diagnosed within the last 6 months.I currently have an infection that is not under control.You are scheduled to receive Bi-VAD support before joining the study.Your heart's pumping ability is very low, less than 30%.I have a mechanical aortic valve that won't be changed to a biological one.My heart failure is not caused by untreated thyroid disease or specific heart muscle conditions.I cannot tolerate blood thinners or certain medications after surgery as per my doctor's advice.My organs are not working properly due to my condition.I have a serious heart valve issue not planned to be fixed during my pump implant.I have a blood clotting disorder like DIC or HIT.I refuse to receive blood transfusions.I need medication to support my heart's pumping action or my heart pumps less blood than it should without medication.I have had an organ transplant.You have a mental health condition, permanent memory problems, or social issues that could affect your participation.I get short of breath with light activity or cannot do any activity due to heart failure.I am 18 years old or older.I do not have any health conditions that could shorten my life to under 2 years, aside from heart failure.If you could become pregnant, you have a positive pregnancy test.
- Group 1: HeartMate 3 (HM3)
- Group 2: Evaheart LVAS (EVA2)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still available slots for prospective participants in this research trial?
"According to the available data on clinicaltrials.gov, this medical investigation is presently open for patient enrolment. This project was initially published on March 31st 2020 and has been revised most recently November 15th 2022."
What is the upper limit to the number of participants included in this clinical investigation?
"Yes, the details posted on clinicaltrials.gov demonstrate that this medical study is currently recruiting participants. This trial was first published on March 31st 2020 and most recently modified on November 15th 2022; these researchers aim to enrol 399 individuals across 12 different sites."
Are there various locations conducting this experiment in the state?
"Presently, the trial is enrolling patients at 12 research sites located in Gainesville, Dallas and Seattle among other urban centres. To minimize travel needs when participating, it may be prudent to choose the closest clinic available."
Share this study with friends
Copy Link
Messenger